<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01480362</url>
  </required_header>
  <id_info>
    <org_study_id>UWT_1_GKV</org_study_id>
    <secondary_id>DRKS00003347</secondary_id>
    <nct_id>NCT01480362</nct_id>
  </id_info>
  <brief_title>Treatment Study of Negative Pressure Wound Therapy for Diabetic Foot Wounds</brief_title>
  <acronym>DiaFu</acronym>
  <official_title>Randomized, Controlled Clinical Trial Evaluating the Efficacy and Clinical Effectiveness of Negative Pressure Wound Therapy for the Treatment of Diabetic Foot Wounds When Compared to Standard Wound Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Witten/Herdecke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kinetic Concepts, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Smith &amp; Nephew Wound Management Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Witten/Herdecke</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      On behalf of a consortium of 19 health insurance companies the Institute for Research in
      Operative Medicine as part of the University of Witten / Herdecke gGmbH is planning and
      conducting a clinical study evaluating the efficacy and effectiveness of negative pressure
      wound therapy in the treatment of wound healing disorders of the foot, which are caused by
      diabetes mellitus.

      This german multicenter study is due to evaluate whether the negative pressure wound therapy
      or the control therapy (standard wound therapy following the guidelines) is superior.

      Patients will be randomly assigned to the two study arms. Both patients and the treatment
      staff know about the specific allocation to the negative pressure wound therapy or standard
      wound therapy arm.

      A photo documentation and a computer-based evaluation of the wound images will be performed.
      This is done centrally by independent examiners, who don`t know neither the patient nor the
      treatment assignment.

      It is believed that the application of the negative pressure wound therapy systems compared
      to standard therapy of diabetic foot wounds will lead more frequent and more rapid to the
      achievement of complete wound closure and that the use of negative pressure wound therapy is
      an effective and safe therapy option for the treatment of diabetic foot wounds in inpatient
      and outpatient care.

      Patient´s to be included into the study should have either a chronic diabetic foot wound
      existing longer than 4 weeks whereas dead tissue components must be completely removed by the
      doctor or a wound after amputation of foot parts.

      The study treatment may have already started in the hospital if applicable. The further wound
      treatment will be mainly performed within outpatient care. Study Participants will return to
      the study centre for regular study visits or even for wound treatment.

      The comparison of the outcomes of both study arms will give valuable information about the
      efficacy of negative pressure wound therapy in inpatient as well as outpatient care. These
      results should be provided until the end of 2016 as a basis for the decision of the Federal
      Joint Committee to answer the question if the negative pressure wound therapy can be approved
      as a standard service for reimbursement by health insurance companies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study project as part of a European tender has the aim to prove efficacy and
      effectiveness of negative pressure wound therapy in the management of patients with chronic
      diabetic foot wounds. The tasks within the study project have been assigned to three
      contractors / institutions.

      On behalf of a consortium of 19 health insurance companies with a central contact consisting
      of the &quot;AOK-Bundesverband GbR&quot;, &quot;Verband der Ersatzkassen e.V.&quot; (vdek) and the &quot;Knappschaft&quot;
      these contractors are responsible for conducting the trial.

      The Institute for Research in Operative Medicine (IFOM) as part of the University of Witten /
      Herdecke gGmbH is responsible for the planning, implementation, analysis and publication of
      the study.

      The Private University of Witten / Herdecke takes over the sponsorship of the study project.
      The duties and responsibilities of the sponsor are transferred to the staff of the Institute
      for Research in Operative Medicine of University of Witten / Herdecke. The financial support
      of the clinical study is provided by the manufacturers of the negative pressure wound therapy
      systems. The task of payment processing and the contractual provisions is taken over by a
      management company &quot;Gesundheitsforen Leipzig&quot;.

      Therapy systems used within the treatment arm of the study will be provided by two
      manufacturers Kinetic Concepts Incorporated (KCI) and Smith &amp; Nephew Inc. All used treatment
      systems bear the CE mark and will be used within normal conditions of clinical routine and
      according to manufacturer's instructions.

      This research project is performed because of a decision of the Federal Joint Committee
      Germany, which states that negative pressure wound therapy can´t be accepted as a standard
      therapy with full reimbursement by the health insurance companies in Germany. This decision
      is based on the rapid report and the final report of the Institute for Quality and Efficiency
      in Health Care, which showed through systematic reviews and meta-analysis of previous study
      projects that an insufficient state evidence regarding the use of negative pressure wound
      therapy for the treatment of acute and chronic wounds is existing.

      This study evaluates the treatment outcome of the application of a technical medical device,
      which is based on the principle of negative pressure wound therapy (treatment group 1:
      Intervention Group) in comparison to standard wound therapy (treatment group 2: Control
      group) in the treatment of chronic foot wounds after adequate (debridement of avital tissue)
      wound preparation or amputation wounds resulting from a scheduled amputation below the ankle
      (talocrural articulation), which are caused in the context of a diabetic foot syndrome.

      The clinical trial is designed as a national, multicenter, prospective, randomized controlled
      superiority study. A blinded evaluation of wound photographs will be performed.

      Patients will be randomized 1:1 to the treatment arm: negative pressure wound therapy and the
      control arm: standard wound therapy.

      Patients will be stratified according to assignment to the participating institution
      (hospital) and by Wagner-Armstrong Stadium.

      The inclusion and exclusion criteria are based on the presence of a diagnosis of a diabetic
      foot wound, the regulatory requirements to the participants in a clinical study and the
      examination and treatment according to current treatment regulations, evidence-based
      guidelines and the specifications of the manufacturers of the medical devices.

      Only patients meeting all inclusion criteria and no exclusion criterion are allowed to be
      included into the trial.

      The aim of this study is to compare the clinical, safety and economic results of both
      treatment arms.

      The primary endpoints to evaluate the efficacy of negative pressure wound therapy in the
      treatment of chronic foot wounds caused by a diabetic foot syndrome are both the number of
      complete wound closure within the maximum treatment period (measured in days) as well as the
      time until complete wound closure. Complete wound closure should be achieved within the
      maximum study treatment period of 16 weeks.

      In addition, secondary clinical endpoints and safety endpoints, patient-reported outcome
      endpoints and health economic endpoints are evaluated.

      The clinical examination includes parameters that can be used for the analysis of resource
      use in the inpatient and outpatient care. This includes a comparative analysis of parameters
      of direct and indirect resource use.

      Primarily the perspective of the Statutory Health Insurance is considered. As a secondary
      perspective the view of society was selected.

      Sample size calculation was performed considering results of existing trials, which revealed
      that a number n = 324 patients must be included in the study in order to carry out the
      analysis of the primary endpoint &quot;Closure rate&quot;.

      In due consideration of screening failures, discontinuation of therapy of any cause and
      losses to Follow-Up a screening of a total of 464 patients must be performed to provide the
      calculated sample size.The primary efficacy analysis is performed using the
      intention-to-treat group.

      Study results will be provided until the end of 2015 to contribute to the final decision of
      the Federal Joint Committee Germany regarding the general admission of negative pressure
      wound therapy as a standard of performance within both medical sectors.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Wound photographs are analysed by blinded outcome assessors</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of achieved and confirmed wound closures within the maximum study treatment time</measure>
    <time_frame>16 weeks</time_frame>
    <description>Complete wound closure is defined as 100% epithelialization; no need for drainage, no need for supportive therapy or a means of assistance and absence of suture material. Wound closure must sustain at least for a period of 14 days and needs to be confirmed within a separate study visit 14 days after the first diagnosis of wound closure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time until wound closure within the maximum study treatment time</measure>
    <time_frame>16 weeks</time_frame>
    <description>Complete wound closure is defined as 100% epithelialization; no need for drainage, no need for supportive therapy or a means of assistance and absence of suture material. Wound closure must sustain at least for a period of 14 days and needs to be confirmed within a separate study visit 14 days after the first diagnosis of wound closure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time until optimal wound bed preparation</measure>
    <time_frame>16 weeks</time_frame>
    <description>Time until optimal preparation of the wound bed for further therapy (granulation of at least 95%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time until wound closure within the observation period</measure>
    <time_frame>6 months</time_frame>
    <description>Time to reach a complete wound closure within the observation period of 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrences</measure>
    <time_frame>6 months</time_frame>
    <description>Recurrences within the observation period of 6 months after complete and confirmed wound closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amputations</measure>
    <time_frame>16 weeks</time_frame>
    <description>Appearance and dimension of amputations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound size</measure>
    <time_frame>16 weeks</time_frame>
    <description>Wound size over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound tissue qualities</measure>
    <time_frame>16 weeks</time_frame>
    <description>Proportion of wound tissue qualities over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of complete wound closures within the observation period</measure>
    <time_frame>6 months</time_frame>
    <description>Number of complete wound closures achieved within the observation period of 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>16 weeks</time_frame>
    <description>Patient`s pain measured at each study visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>6 months</time_frame>
    <description>EQ-5D at inclusion, end of maximum treatment time or end of therapy, Follow-Up after 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Direct costs</measure>
    <time_frame>within a maximum treatment time of 16 weeks or until end of therapy</time_frame>
    <description>direct medical resource use and costs: hospitalization, outpatient contact with study centre and other providers, reimbursable drugs, medical sundries, adjuvants, reimbursable services direct non-medical resource use and costs: services, travel costs, expenditure of time for patients, expenditure of time for lay care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Indirect costs</measure>
    <time_frame>within a maximum treatment time of 16 weeks or until end of therapy</time_frame>
    <description>disability, disability pension, premature death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serious adverse events</measure>
    <time_frame>6 months</time_frame>
    <description>All adverse events that result in death, are life-threatening, require inpatient hospitalization or causes prolongation of existing hospitalization, result in persistent or significant disability/incapacity, are a congenital anomaly/birth defect, or require intervention to prevent permanent impairment or damage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>16 weeks</time_frame>
    <description>wound specific and device specific adverse events within the maximum study treatment time</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">360</enrollment>
  <condition>Foot Ulcer, Diabetic</condition>
  <arm_group>
    <arm_group_label>Negative Pressure Wound Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The therapy involves the controlled application of sub-atmospheric pressure to the local wound environment,using a sealed wound dressing connected to a vacuum pump.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Wound Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard wound therapy according to current evidence-based guideline(basic and advanced methods of wound treatment)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Negative Pressure Wound Therapy</intervention_name>
    <description>Used therapy systems:
KCI. V.A.C. Freedom; Acti V.A.C.; INFO V.A.C. to be used with the V.A.C. Granufoam (black), V.A.C. Granufoam Silver and V.A.C. WhiteFoam Smith &amp; Nephew: Renasys GO and Renasys EZ Plus to be used with the Renassys-F/P and Renassys-G Use of the medical devices and applicable consumption items according to manufacturers guidelines and FDA regulations.</description>
    <arm_group_label>Negative Pressure Wound Therapy</arm_group_label>
    <other_name>Vacuum assisted closure</other_name>
    <other_name>Vacuum assisted wound closure</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Wound Therapy</intervention_name>
    <description>Standard wound therapy according to current evidence-based guideline(basic and advanced methods of wound treatment)</description>
    <arm_group_label>Standard Wound Therapy</arm_group_label>
    <other_name>Standard Conventional Wound Therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presence of diabetes mellitus

          -  Presence of a foot wound (chronic wounds; amputation wounds) Wagner stage 2-4

          -  Existence of the foot wound for at least 4 weeks

          -  Signed informed consent form

          -  Patient's eligibility of NPWT in the opinion of the treating physician

        Exclusion Criteria:

          -  Age &lt;18 years

          -  Non-Compliance

          -  Pregnancy

          -  Allergies regarding the release of substances from components of each treatment arm

          -  Severe anemia, wich was not caused by an infection

          -  Simultaneous participation of patients in another interventional study / previous
             participation in the same study

          -  Use of NPWT systems to the study-related foot lesion within a period of 6 weeks prior
             to study inclusion

          -  Presence of necrotic tissue with eschar, which can not be removed

          -  Untreated osteitis or osteomyelitis

          -  Not examined / unexplored fistula

          -  Malignancy of the wound

          -  Exposed: nerves, blood vessels, anastomotic site

          -  ambulant NPWT of patients receiving anticoagulants (especially heparinization or
             marcumar therapy) or with otherwise highly impaired clotting function, which have a
             risk of circulatory relevant bleeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dörthe Seidel</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut für Forschung in der Operativen Medizin der Privaten Universität Witten / Herdecke gGmbH</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Edmund AM Neugebauer, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Institut für Forschung in der Operativen Medizin der Privaten Universität Witten / Herdecke gGmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Diabetes Klinik GmbH &amp; Co KG</name>
      <address>
        <city>Bad Mergentheim</city>
        <zip>97980</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus, Königin Elisabeth Herzberge gGmbH</name>
      <address>
        <city>Berlin</city>
        <zip>10365</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Franziskus-Krankenhaus Berlin, Abteilung für Innere Medizin</name>
      <address>
        <city>Berlin</city>
        <zip>10787</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Bielefeld, Klinik für Allgemeine und Innere Medizin</name>
      <address>
        <city>Bielefeld</city>
        <zip>33604</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gerhard Rothenaicher, Facharzt für Chirurgie, München Bogenhausen</name>
      <address>
        <city>Bogenhausen</city>
        <zip>81927</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Knappschaftskrankenhaus Bottrop Klinik für Gefäßchirurgie</name>
      <address>
        <city>Bottrop</city>
        <zip>46242</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tagesklinik Buchloe</name>
      <address>
        <city>Buchloe</city>
        <zip>86807</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Darmstadt, Gefäß- und Endovascularchirurgie</name>
      <address>
        <city>Darmstadt</city>
        <zip>64283</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marienhospital Dortmund-Hombruch, Klinik für Innere Medizin / Diabetologie</name>
      <address>
        <city>Dortmund</city>
        <zip>44225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetische Schwerpunktpraxis</name>
      <address>
        <city>Duisburg</city>
        <zip>47119</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Döbeln</name>
      <address>
        <city>Döbeln</city>
        <zip>04720</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Malteser Krankenhaus - St. Franziskus-Hospital, Medizinische Klinik I, Abt. f. Diabetologie</name>
      <address>
        <city>Flensburg</city>
        <zip>24939</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Frankfurt (Oder), Klinik für Gefäßchirurgie</name>
      <address>
        <city>Frankfurt (Oder)</city>
        <zip>15236</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Goethe Universität Frankfurt am Main, Klinik für Gefäß- und Endovascularchirurgie</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bürgerhospital, Klinik für Diabetologie und Ernährungsmedizin</name>
      <address>
        <city>Frankfurt</city>
        <zip>60318</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weißeritztal-Kliniken GmbH Klinik für Gefäßchirurgie-, vaskuläre und endovaskuläre Chirurgie, Phlebologie</name>
      <address>
        <city>Freital</city>
        <zip>01705</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helfenstein Klinik Geislingen, Allgemein- und Viszeralchirurgie</name>
      <address>
        <city>Geislingen</city>
        <zip>73312</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Kliniken Harburg</name>
      <address>
        <city>Hamburg</city>
        <zip>21075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASKLEPIOS Westklinikum Hamburg GmbH</name>
      <address>
        <city>Hamburg</city>
        <zip>22559</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paracelsusklinik am Silbersee, Wundzentrum Hannover</name>
      <address>
        <city>Hannover-Langenhagen</city>
        <zip>30851</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westküstenklinikum Heide, Klinik für Visceral- und Gefäßchirurgie</name>
      <address>
        <city>Heide</city>
        <zip>25746</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Karlsruhe GmbH</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alexianer Krankenhaus Krefeld GmbH, Klinik für Allgemein-, Visceral- und Thoraxchirurgie</name>
      <address>
        <city>Krefeld</city>
        <zip>47805</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Schlotmann - Hochlenert - Zavaleta - Haberstock</name>
      <address>
        <city>Köln</city>
        <zip>50733</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chirurgische Praxisgemeinschaft am Bayenthalgürtel, Praxis Dr. med. Gerald Engels</name>
      <address>
        <city>Köln</city>
        <zip>50968</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Porz am Rhein, Klinik für Gefäßchirurgie</name>
      <address>
        <city>Köln</city>
        <zip>51149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Remigius Krankenhaus Opladen</name>
      <address>
        <city>Leverkusen</city>
        <zip>51379</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Ludwigsburg, Klinik für Gefäßchirurgie, vaskuläre und endovaskuläre Chirurgie</name>
      <address>
        <city>Ludwigsburg</city>
        <zip>71640</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetologikum Ludwigshafen, Diabetes-Schwerpunktpraxis</name>
      <address>
        <city>Ludwigshafen</city>
        <zip>67059</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uniklinik Lübeck, Klinik für Allgemeine Chirurgie</name>
      <address>
        <city>Lübeck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kliniken Maria Hilf GmbH</name>
      <address>
        <city>Mönchengladbach</city>
        <zip>41061</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städt. Klinikum Bogenhausen</name>
      <address>
        <city>München</city>
        <zip>81477</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut für Diabetesforschung Münster GmbH</name>
      <address>
        <city>Münster</city>
        <zip>48145</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Neunkirchen gGmbH</name>
      <address>
        <city>Neunkirchen</city>
        <zip>66538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Drs. Alter, Heim, Pourhassan</name>
      <address>
        <city>Oberhausen</city>
        <zip>46145</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ortenau Klinikum Offenburg, Klinik für Allgemein-, Viszeral- und Gefäßchirurgie</name>
      <address>
        <city>Offenburg</city>
        <zip>77654</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Dorothea Christiane Erxleben Quedlinburg GmbH, Klinik für Allgemein-, Visceral- und Gefäßchirurgie</name>
      <address>
        <city>Quedlinburg</city>
        <zip>06484</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hegau-Bodensee Klinikum Radolfzell (HBK), Klinik für Innere Medizin</name>
      <address>
        <city>Radolfzell am Bodensee</city>
        <zip>78315</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thüringen Kliniken &quot;Georgius Agricola&quot;, Klinik für Gefäßchirurgie</name>
      <address>
        <city>Saalfeld</city>
        <zip>07318</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Marienkrankenhaus Siegen gGmbH, Klinik für Gastroenterologie</name>
      <address>
        <city>Siegen</city>
        <zip>57072</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mariannen-Hospital Werl, Abteilung für Chirurgie</name>
      <address>
        <city>Werl</city>
        <zip>59457</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HSK - Dr. Horst Schmidt Kliniken GmbH</name>
      <address>
        <city>Wiesbaden</city>
        <zip>65199</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2011</study_first_submitted>
  <study_first_submitted_qc>November 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 28, 2011</study_first_posted>
  <last_update_submitted>August 18, 2017</last_update_submitted>
  <last_update_submitted_qc>August 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Witten/Herdecke</investigator_affiliation>
    <investigator_full_name>Doerthe Seidel</investigator_full_name>
    <investigator_title>Interim Scientific Leader of the Centre for Clinical Trials and Innovation</investigator_title>
  </responsible_party>
  <keyword>Diabetic foot wound</keyword>
  <keyword>Amputation wound</keyword>
  <keyword>Chronic wound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

